Therapy with interferon-β modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis
Authors:
- Franca MarinoFMFranca Marino
- Raffaella BombelliRBRaffaella Bombelli
- Emanuela RasiniEREmanuela Rasini
- Marta MontiMMMarta Monti
- Marco FerrariMFMarco Ferrari
- Angelo GhezziAGAngelo Ghezzi
- Giancarlo ComiGCGiancarlo Comi
- Sergio LecchiniSLSergio Lecchini
- Marco CosentinoMarco Cosentino
- 1 December 2008
- journal article
- clinical trial
- Published by Elsevier in Experimental Neurology
- Vol. 214 (2) , 315-321
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Interferon-γ and interferon-β affect endogenous catecholamines in human peripheral blood mononuclear cells: Implications for multiple sclerosisJournal of Neuroimmunology, 2005
- Unravelling dopamine (and catecholamine) physiopharmacology in lymphocytes: open questionsTrends in Immunology, 2003
- Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosisJournal of Neuroimmunology, 2002
- Interactions between the Sympathetic Nervous System and the Immune SystemBrain, Behavior, and Immunity, 1999
- Measurements of catecholamine‐mediated apoptosis of immunocompetent cells by capillary electrophoresisElectrophoresis, 1997
- Bromocriptine Therapy in Multiple SclerosisClinical Neuropharmacology, 1994
- Innervation of lymphoid organs and implications in development, aging, and autoimmunityInternational Journal of Immunopharmacology, 1992
- Blood Lymphocyte ?-Adrenergic Receptors in Multiple SclerosisAnnals of the New York Academy of Sciences, 1988
- Chemical sympathectomy augments the severity of experimental allergic encephalomyelitisJournal of Neuroimmunology, 1988
- Is multiple sclerosis the equivalent of Parkinson's disease for noradrenaline?Medical Hypotheses, 1987